Filing metadata

Accession number
0001127602-21-029466
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Nov 17, 2021
Reporting period
Nov 04, 2021
Description
Insider transaction

Explore SEC Filings Hub